Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
Masato Furuhashi, Megumi Matsumoto, Takayo Murase, et al.
Journal of Diabetes Investigation (2018) Vol. 10, Iss. 4, pp. 1059-1067
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity
Masato Furuhashi
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 5, pp. E827-E834
Closed Access | Times Cited: 246
Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
Masato Furuhashi
Journal of Atherosclerosis and Thrombosis (2019) Vol. 26, Iss. 3, pp. 216-232
Open Access | Times Cited: 237
Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential
Arrigo F.G. Cicero, Federica Fogacci, Valentina Di Micoli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7027-7027
Open Access | Times Cited: 42
Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors
Milton Packer
Circulation Heart Failure (2020) Vol. 13, Iss. 9
Open Access | Times Cited: 135
Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP
Todd A. Johnson, H. A. Jinnah, Naoyuki Kamatani
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 133
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
Marenao Tanaka, Kazuma Mori, Satoko Takahashi, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 3, pp. 700-711
Closed Access | Times Cited: 38
Purine metabolism in the development of osteoporosis
Keda Yang, Jie Li, Lin Tao
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113784-113784
Open Access | Times Cited: 33
Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel
Sethapong Lertsakulbunlue, Tanatip Sangkool, Varathpavee Bhuriveth, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Differential regulation of hypoxanthine and xanthine by obesity in a general population
Masato Furuhashi, Masayuki Koyama, Yukimura Higashiura, et al.
Journal of Diabetes Investigation (2020) Vol. 11, Iss. 4, pp. 878-887
Open Access | Times Cited: 49
U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2
Kazuma Mori, Masato Furuhashi, Marenao Tanaka, et al.
Hypertension Research (2020) Vol. 44, Iss. 1, pp. 107-116
Closed Access | Times Cited: 41
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses
Kazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1110-1121
Closed Access | Times Cited: 16
Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study
Norie Saito, Masato Furuhashi, Masayuki Koyama, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10‐Year Period in Both Male and Female Subjects
Yukimura Higashiura, Masato Furuhashi, Marenao Tanaka, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 14
Open Access | Times Cited: 28
Effects of febuxostat therapy on circulating adipokine profiles in patients with overweight or obesity and asymptomatic hyperuricemia: A randomized controlled study
Meijuan Dong, Zhaohui Cui, Yuanyuan Liu, et al.
Obesity Facts (2024) Vol. 17, Iss. 5, pp. 524-534
Open Access | Times Cited: 4
High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population
Yukimura Higashiura, Marenao Tanaka, Kazuma Mori, et al.
European Heart Journal Open (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 18
Fatty acid binding proteins-mediated mitochondrial dysfunction in the development of age-related diseases: A review
Xingxing Ren, C. Jin, Qilin Li, et al.
International Journal of Biological Macromolecules (2025), pp. 142913-142913
Closed Access
Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals
Marenao Tanaka, Satoko Takahashi, Yukimura Higashiura, et al.
Journal of Diabetes Investigation (2021) Vol. 13, Iss. 5, pp. 878-888
Open Access | Times Cited: 23
An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort
Marenao Tanaka, Tatsuya Sato, Keisuke Endo, et al.
Hypertension Research (2023) Vol. 46, Iss. 12, pp. 2635-2645
Closed Access | Times Cited: 9
Annual change in plasma xanthine oxidoreductase activity is associated with changes in liver enzymes and body weight
Masato Furuhashi, Masayuki Koyama, Megumi Matsumoto, et al.
Endocrine Journal (2019) Vol. 66, Iss. 9, pp. 777-786
Open Access | Times Cited: 25
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 23
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 22
Association Between Triglyceride-Glucose Index and Serum Uric Acid Levels: A Biochemical Study on Anthropometry in Non-Obese Type 2 Diabetes Mellitus Patients
Yu Luo, Jianan Hao, Xiaoyu He, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 3447-3458
Open Access | Times Cited: 14
Fatty Acid-Binding Protein 4-Mediated Regulation Is Pivotally Involved in Retinal Pathophysiology: A Review
Hiroshi Ohguro, Megumi Watanabe, Fumihito Hikage, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7717-7717
Open Access | Times Cited: 2
Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy
Kaku Itoh, Masato Furuhashi, Yosuke Ida, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top